Search results
Results from the WOW.Com Content Network
Risk of bleeding – Spinal cord stimulator trial and implant have been identified as procedures with high risk of serious intraspinal bleeding, which can cause permanent neurologic damage. Appropriate planning for discontinuation and reinstitution of anti-platelet and anticoagulant medications is necessary prior to placement of a stimulator.
Many studies have been initiated using the sacral nerve stimulation (SNS) technique to treat patients that suffer with urinary problems. [citation needed] When applying this procedure, proper patient screening is essential, because some disorders that affect the urinary tract (like bladder calculus or carcinoma in-situ) have to be treated differently.
The stimulation, applied over the lumbar spinal cord, works by activating large diameter afferent fibers entering the spinal cord, [17] [18] which then transsynaptically activate and engage spinal neuronal networks. [19] The same target structures can also be activated by transcutaneous electrodes placed over the lower thoracic spine and ...
Electrical stimulation using implantable devices came into modern usage in the 1980s and its techniques and applications have continued to develop and expand. [16] Recent reviews highlight how neuromodulation is increasingly utilized across multiple medical subspecialties, providing clinicians with novel therapeutic options for both painful and non-painful complex disorders. [17]
Neurostimulation for chronic pain is primarily through the use of spinal cord stimulators. [11] These devices deliver electrical stimulation to different areas of the spine based on where they are implanted. Since 2012, Medtronic has produced spinal cord stimulators with accelerometers that can predict the patient's position. The device can be ...
(This statement is correct for all commercially available stimulators except MyndMove stimulator (developed my Milos R. Popovic), which has implemented a new stimulation pulse that allows the stimulator to generate muscle contractions without causing discomfort during stimulation, which is a common problem with commercially available ...
From 1969 onwards Giles Brindley [1] developed the sacral anterior root stimulator, with successful human trials from the early 1980s onwards. Although both sphincter and detrusor muscles are stimulated at the same time, the slower contraction kinetics of the bladder wall (smooth muscle tissue) compared to the sphincter (striated muscle tissue) mean that voiding occurs between the stimulation ...
The procedure is performed in an operating room. [6] The S3 foramen are identified and the wires are placed. [6] A pocket is created for the placement of the stimulator. [6] The stimulator is connected to the placed wires and secured into the pocket in the buttock. [6] The patient and the physician work to optimize the settings.